Accelerator-Based Production of Mo-99

Session Organizers:
Tom Ruth, TRIUMF, Canada
George F. Vandergrift III, Argonne National Laboratory, United States

Facing the shutdown of the NRU and other research reactors that are used for the production of Mo-99 by the fission of U-235, a number of initiative routes to 99Mo/99mTc have been proposed based on the use of accelerators. The participants in this session will describe the various routes and the status of their efforts. Expected proposals include the use of electron linacs, low energy cyclotrons, high energy proton accelerators, and accelerator based neutron generators.

INVITED PAPERS

Accelerator Production of Mo99 Utilizing Electron Accelerators
Jim Harvey, NorthStar Medical Radioisotopes, LLC, United States

Target materials for accelerator production of 99mTc
Suzanne Lapi, Washington University School of Medicine, United States

Linear Accelerator Production of Mo-99 – the Canadian Experience
Kennedy Mang’era, Radiopharmacy, Health Sciences Centre Winnipeg, Canada

Radiation Protection and Construction, Commissioning and Production of Mo-99 at the Medical Isotope Facility at Canadian Light Sources
Pradyot Chowdhury, RSO – Medical Isotopes Project, Canadian Light Source Inc., Canada

Recent Progress in the Design and Experimental Activities Supporting the Commercial Electron Accelerator Production of the Medical Radioisotope Mo-99
Gregory E. Dale, Los Alamos National Laboratory, United States

Update on the University of Alberta's TR24 production of Tc-99m
Katherine Gagnon, Cross Cancer Institute, Department of Oncology, Canada

Supplying Alternative Mo-99/Tc-99m Production: Availability of Mo-100/Mo-98
Patrick Hardy, ISOFLEX USA, United States

Current is King: The Direct Production of 99mTc Via the 100Mo(p,2n) Channel on Small Medical Cyclotrons
Paul Schaffer, TRIUMF, Canada